반도체 오를 때 소외당한 바이오, 이제 다시 주목할 때!_26.05.07. | 박현지, 여도은, 허재무 [아침N투자]

Watch on YouTube ↗  |  May 07, 2026 at 01:53  |  29:25  |  3PRO TV (삼프로TV)

Summary

The video covers weekly ETF trends, highlighting inflows into AI and tech, and underperformance in biotech. The host Park Hyun-ji recommends buying Korean biotech ETFs on weakness due to a favorable patent cliff and expected rotation away from semiconductors. New ETF listings include a robot/AI active ETF and a low-fee Bitcoin spot ETF from Morgan Stanley.

  • ETF flows show continued preference for AI, semis, and power stocks.
  • Biotech is underowned but fundamentals are strong due to a patent cliff starting 2025.
  • Park Hyun-ji advocates gradual accumulation of Korean biotech ETFs as a contrarian play.
  • US biotech passive ETF IBB is noted as better long-term than active alternatives.
  • New listings include KODEX US Robot AI Active ETF and Morgan Stanley Bitcoin ETF.
  • Nvidia earnings are seen as a potential inflection point for the AI theme.
  • Google outperformed Meta in recent earnings due to AI spending concerns.
  • Risk-on sentiment persists with Bitcoin rising despite geopolitical tensions.
Trade Ideas
Buy Korean biotech ETFs on weakness.
The biotech sector is currently underowned as money flows to AI and semiconductors, but fundamentals are strong due to a patent cliff from 2025 to 2028 that will drive demand for biosimilars and technology transfers. Current valuations are low, making this a buying opportunity. The speaker expects eventual capital rotation into biotech and recommends gradual accumulation of Korean biotech ETFs.
Up Next

This 3PRO TV (삼프로TV) video, published May 07, 2026, features Park Hyun-ji discussing KODEX Bio Healthcare Active ETF, XLV, TIGER Technology Transfer Bio Active ETF. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: Park Hyun-ji  · Tickers: KODEX Bio Healthcare Active ETF, XLV, TIGER Technology Transfer Bio Active ETF